Statement of Changes in Beneficial Ownership (Form 4)

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Sit Swan 2. Issuer Name and Ticker or Trading Symbol Stablecoin Development Corp [SDEV] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O STABLECOIN DEVELOPMENT CORPORATION, 222 LAKEVIEW AVE, SUITE 800 3. Date of Earliest Transaction (Month/Day/Year) 06/09/2024 (Street) WEST PALM BEACH, FL 33401 4. If Amendment, Date Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, par value $0.01 per share 06/09/2024(3) M 5(1)(2) A $ 0 15(4) D Common Stock, par value $0.01 per share 05/28/2025(3) M 172(1)(2) A $ 0 187(4) D Common Stock, par value $0.01 per share 10/16/2026(3) M 6,000(1)(2) A $ 0 6,187(4) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	06/09/2024(3)		M			5(1)(2)	(3)	(3)	Common Stock, par value $0.01 per share	5(1)(2)	$ 0	172(4)	D
Restricted Stock Units	(3)	05/28/2025(3)		M			172(1)(2)	(3)	(3)	Common Stock, par value $0.01 per share	172(1)(2)	$ 0	0 (4)	D
Restricted Stock Units	(3)	10/16/2025		A		6,000(1)(2)		(3)	(3)	Common Stock, par value $0.01 per share	6,000(1)(2)	$ 0	6,000(4)	D
Restricted Stock Units	(3)	10/16/2026		M			6,000(1)(2)	(3)	(3)	Common Stock, par value $0.01 per share	6,000(1)(2)	$ 0	140,000(4)	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Sit Swan C/O STABLECOIN DEVELOPMENT CORPORATION 222 LAKEVIEW AVE, SUITE 800 WEST PALM BEACH, FL 33401	X

Signatures

/s/ Tommy Law as attorney in fact for Swan Sit		11/05/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	All share and RSU amounts reported in this Form 4 have been adjusted to give effect to the Issuer's 1-for-5 reverse stock split effective February 20, 2026 (the "2026 Reverse Split"). On a pre-2026 Reverse Split basis, (i) the RSUs granted on October 16, 2025, and the shares of common stock issued upon settlement of such RSUs on October 16, 2026, each covered 30,000 RSUs or shares, as applicable, which equals 6,000 RSUs or shares on a post-2026 Reverse Split basis; (ii) the RSUs settled on May 28, 2025, and the shares of common stock issued upon such settlement, each covered 858 RSUs or shares, as applicable, which equals 172 RSUs or shares on a post-2026 Reverse Split basis; and (iii) the RSUs settled on June 9, 2024, and the shares of common stock issued upon such settlement, each covered 25 RSUs or shares, as applicable, which equals 5 RSUs or shares on a post-2026 Reverse Split basis.
(2)	The RSUs granted on May 28, 2024 were reported on the Reporting Person's Form 4 filed on May 30, 2024 as 30,000 RSUs, an amount that did not give effect to the Issuer's 1-for-35 reverse stock split effective May 30, 2024 (the "2024 Reverse Split"). After giving effect to each of the 2024 Reverse Split and the 2026 Reverse Split, such 30,000 RSUs equal 172 RSUs. The RSUs granted on June 9, 2023 were reported on the Reporting Person's Form 4 filed on June 13, 2023 as 858 RSUs; after giving effect to each of the 2024 Reverse Split and the 2026 Reverse Split, such 858 RSUs equal 5 RSUs. Fractional shares and RSUs resulting from the 2024 Reverse Split and the 2026 Reverse Split were rounded up to the nearest whole share or RSU, as applicable.
(3)	Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs granted on June 9, 2023 vested in full on June 9, 2024, the first anniversary of the grant date. The RSUs granted on May 28, 2024 vested in full on May 28, 2025, the first anniversary of the grant date, and the RSUs granted on October 16, 2025 vested in full on October 16, 2026, the first anniversary of the grant date, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs have no expiration date.
(4)	The Reporting Person's Form 4 reporting the RSUs granted on March 31, 2026, filed on April 2, 2026, did not include (i) the 6,000 RSUs (on a post-2026 Reverse Split basis) granted on October 16, 2025, which were then held by the Reporting Person and unvested, or (ii) the shares of common stock held by the Reporting Person, including shares acquired upon settlement of RSUs on May 21, 2022, May 11, 2023, June 9, 2024 and May 28, 2025. The holdings reported in this Form 4 correct the holdings previously reported. The 140,000 RSUs granted on March 31, 2026, as reported on such prior Form 4, are not affected by the transactions reported herein and continue to be held by the Reporting Person. The Reporting Person currently beneficially owns 140,000 RSUs.
Remarks: This Form 4 is filed late due to administrative oversight, compounded by the change in control of the Issuer and the related transition of the Issuer's management. This Form 4 is being filed as soon as reasonably practicable following discovery of the oversight. Each of the following transactions was required to be reported within two business days and is reported late on this Form 4: (i) the June 9, 2024 vesting of RSUs; (ii) the May 28, 2025 vesting of RSUs; (iii) the October 16, 2025 grant of RSUs; and (iv) the October 16, 2026 vesting of RSUs.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.